self-PoweRed cONductimeter for digiTalization of rapid mOlecular diagnostics

PRONTO aims to develop a low-cost, self-powered conductimetric sensor for rapid, sensitive detection of infectious diseases, making advanced testing accessible in low- and medium-income countries.

Subsidie
€ 150.000
2023

Projectdetails

Introduction

Despite huge progress in prevention and treatment over the past century, infectious diseases still impose a great health burden. For this reason, lab-centralised immunoassays and nucleic acid tests that allow for specific pathogen identification with limits of detection reaching a few copies per ml of sample are readily available and supported by both national and private health systems in the developed world.

Accessibility Issues

However, these tests are neither affordable nor accessible to patients in low- and medium-income countries. Fortunately, lateral flow antigen-based tests have proven to be a fast, reliable, and affordable tool to detect a wide range of pathogens.

Limitations of Current Tests

However, such tests suffer from cross-reactivity with related bacterial or viral species and, more importantly, they often require 10^5 pathogens per mL to yield a positive result.

Clinical and Technological Need

It becomes clear that there is a clinical and technological need to develop rapid tests that combine PCR sensitivity—able to detect one copy per mL—with lateral flow affordability.

Proposed Solution

PRONTO proposes a novel low-cost, sustainable, and self-powered readout system for nucleic acid detection based on conductimetry. The key component consists of a paper-based and single-use self-powered conductimetric sensor developed during the ERC Consolidator Grant SUPERCELL.

Unique Sensing Approach

The sensing approach is unique and minimalistic, as it breaks the classic paradigm of sensor-electronics-battery. The sensor and the power source are merged into one element while making the detection system energetically autonomous.

Global Impact

The simplicity of the approach will enable the deployment of highly sensitive and digital tests for infectious diseases at affordable prices and in a sustainable manner at a global scale.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-6-2023
Einddatum30-11-2024
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICASpenvoerder

Land(en)

Spain

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

ECL-based Infectious Pathogen (bio)SEnsor

ECLIPSE aims to develop a portable, cost-effective platform using ultrasensitive detection methods for rapid identification of infectious pathogens, enhancing response to future pandemics.

€ 2.683.996
EIC Transition

Leveraging CRISPR-Cas for fast and accurate point-of-care diagnostics

Scope Biosciences aims to validate its patented CRISPR-Cas diagnostic technology, scopeDx, for rapid, accurate, and adaptable point-of-care diagnostics in healthcare.

€ 2.498.125
MIT R&D Samenwerking

Microfluïde assay on-a-chip voor detectie bacteriële infecties

Levels Diagnostics en Digi.Bio ontwikkelen een innovatieve lab-on-a-chip test voor snelle en betrouwbare differentiatie tussen virale en bacteriële luchtweginfecties om onnodig antibioticagebruik te verminderen.

€ 180.528